Wedbush Securities’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Wedbush Securities’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-11,090	Closed	-$691K	–	775
2015 Q2	$691K	Sell	11,090 -1,906	-15%	-$119K	0.13%	195
2015 Q1	$803K	Buy	12,996 +490	+4%	+$29.1K	0.14%	168
2014 Q4	$675K	Buy	12,506 +26	+0.2%	+$1.42K	0.1%	191
2014 Q3	$662K	Buy	12,480 +1,580	+14%	+$80.3K	0.1%	199
2014 Q2	$566K	Buy	+10,900	New	+$526K	0.09%	236

Other funds holding XPH

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

PVH

Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Hoxton Financial Shepherdstown, West Virginia $194M AUM 6.21% 1-Year Est. Return

Wedbush Securities's XPH Position: Q3 2015 in Review

Wedbush Securities sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q3 2015, closing a stake of 11,090 shares — an estimated $691K sold.

Wedbush Securities first reported a position in XPH in Q2 2014 and held it in 5 quarters. The position peaked at $803K in Q1 2015. 77 funds tracked by Wall St. Rank hold XPH as of Q3 2015.

Wedbush Securities reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q3 2015 after selling out during the quarter.
Wedbush Securities sold 11,090 State Street SPDR S&P Pharmaceuticals ETF shares in Q3 2015, an estimated $691K.
Wedbush Securities first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q2 2014 and held it in 5 quarters.
Wedbush Securities's State Street SPDR S&P Pharmaceuticals ETF position peaked at $803K in Q1 2015.
77 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q3 2015.

Based on Wedbush Securities's 13F filing for Q3 2015, filed 28 Oct 2015.